Morgan Stanley’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Sell
403,381
-321,197
-44% -$2.89M ﹤0.01% 4591
2025
Q4
$7.75M Buy
724,578
+235,210
+48% +$2.58M ﹤0.01% 3840
2025
Q3
$6.1M Sell
489,368
-176,282
-26% -$1.81M ﹤0.01% 3991
2025
Q2
$6.8M Sell
665,650
-363,940
-35% -$3.2M ﹤0.01% 3801
2025
Q1
$8.13M Buy
1,029,590
+184,912
+22% +$2.28M ﹤0.01% 3530
2024
Q4
$6.63M Buy
844,678
+218,841
+35% +$1.1M ﹤0.01% 3754
2024
Q3
$1.97M Sell
625,837
-61,462
-9% -$181K ﹤0.01% 4663
2024
Q2
$1.95M Buy
687,299
+253,370
+58% +$1.81M ﹤0.01% 4589
2024
Q1
$6.83M Sell
433,929
-829,695
-66% -$14M ﹤0.01% 3657
2023
Q4
$24.8M Buy
1,263,624
+787,758
+166% +$13.7M ﹤0.01% 3140
2023
Q3
$9.69M Sell
475,866
-75,998
-14% -$1.91M ﹤0.01% 3151
2023
Q2
$16.1M Sell
551,864
-11,192
-2% -$307K ﹤0.01% 2695
2023
Q1
$15.8M Sell
563,056
-270,874
-32% -$6.95M ﹤0.01% 2685
2022
Q4
$15.5M Sell
833,930
-7,313
-0.9% -$125K ﹤0.01% 2599
2022
Q3
$13.2M Buy
841,243
+4,729
+0.6% +$106K ﹤0.01% 2657
2022
Q2
$21.1M Sell
836,514
-98,539
-11% -$2.95M ﹤0.01% 2233
2022
Q1
$33.8M Buy
935,053
+768,615
+462% +$37.8M ﹤0.01% 1594
2021
Q4
$12.8M Sell
166,438
-128,543
-44% -$11.3M ﹤0.01% 2660
2021
Q3
$28.4M Sell
294,981
-40,154
-12% -$4.38M ﹤0.01% 1734
2021
Q2
$35.8M Sell
335,135
-21,515
-6% -$2.12M ﹤0.01% 1582
2021
Q1
$31.9M Buy
356,650
+15,942
+5% +$1.75M ﹤0.01% 1519
2020
Q4
$34.2M Buy
340,708
+222,575
+188% +$16.6M 0.01% 1378
2020
Q3
$5.78M Sell
118,133
-85,145
-42% -$4.09M ﹤0.01% 2575
2020
Q2
$8.3M Buy
203,278
+156,443
+334% +$4.49M ﹤0.01% 2135
2020
Q1
$722K Sell
46,835
-438
-0.9% -$9.21K ﹤0.01% 4161
2019
Q4
$1.07M Buy
+47,273
New +$775K ﹤0.01% 4491

Other funds holding CRNC

Morgan Stanley's CRNC Position: Q1 2026 in Review

Morgan Stanley reduced its Cerence (CRNC) stake by 44% in Q1 2026, selling an estimated $2.89M and leaving 403,381 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4591.

Morgan Stanley first reported a position in CRNC in Q4 2019 and has held it in 26 quarters since. The position peaked at $35.8M in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Morgan Stanley held 403,381 shares of Cerence worth $2.55M as of Q1 2026.
  • Morgan Stanley sold 321,197 Cerence shares in Q1 2026, an estimated $2.89M.
  • Cerence made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4591 holding.
  • Morgan Stanley first reported a position in Cerence in Q4 2019 and has held it in 26 quarters since.
  • Morgan Stanley's Cerence position peaked at $35.8M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.